Skip to main content
. 2022 Feb 28;10(3):561. doi: 10.3390/biomedicines10030561

Figure 3.

Figure 3

The dopamine signaling pathway that inactivates AKT1 and maintains activity of GSK3β by preventing its phosphorylation by AKT1.